Ionis Pharmaceuticals (IONS) Inventory Average (2018 - 2026)

Ionis Pharmaceuticals' Inventory Average history runs 9 years deep, the most recent figure standing at $7.8 million for Q1 2026.

• On a quarterly basis, Inventory Average fell 35.02% year-over-year to $7.8 million in Q1 2026; TTM through Mar 2026 was $7.8 million, a 35.02% decrease from a year earlier, with the FY2025 full-year figure at $11.3 million, up 13.07% from the prior year.
• Inventory Average declined to $7.8 million in Q1 2026 per IONS's latest filing, from $10.3 million in the prior quarter.
• Across five years, Inventory Average topped out at $29.5 million in Q2 2024 and bottomed at $7.8 million in Q1 2026.
• The 5-year median for Inventory Average is $20.5 million (2024), against an average of $19.0 million.
• Across the five-year window, Inventory Average rose 26.49% in 2023 and tumbled 66.85% in 2025, its largest moves.
• Year by year, Inventory Average stood at $21.3 million in 2022, then fell by 22.5% to $16.5 million in 2023, then rose by 23.85% to $20.5 million in 2024, then sank by 49.91% to $10.3 million in 2025, then decreased by 23.94% to $7.8 million in 2026.
• Per Business Quant, the three latest IONS Inventory Average figures stand at $7.8 million (Q1 2026), $10.3 million (Q4 2025), and $9.5 million (Q3 2025).